Synergistic activity of JAK2 and BCL-2 inhibition against B-cell acute lymphoblastic leukemia

被引：0
|
作者：
Rinella, Sean [1 ]
Hess, Nicholas [1 ]
Bell, Haley [1 ]
Shi, Lei [1 ]
Rui, Lixin [1 ]
Capitini, Christian [1 ]
机构：
[1] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22002
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemia
    Charlotte E. J. Downes
    Barbara J. McClure
    John B. Bruning
    Elyse Page
    James Breen
    Jacqueline Rehn
    David T. Yeung
    Deborah L. White
    npj Precision Oncology, 5
  • [22] Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemia
    Downes, Charlotte E. J.
    McClure, Barbara J.
    Bruning, John B.
    Page, Elyse
    Breen, James
    Rehn, Jacqueline
    Yeung, David T.
    White, Deborah L.
    NPJ PRECISION ONCOLOGY, 2021, 5 (01)
  • [23] Dual Sphingosine Kinase and Bcl-2 Inhibition Exhibits Synergistic Cell Death in Acute Myeloid Leukemia
    Lewis, Alexander C.
    D'Andrea, Richard
    Powell, Jason A.
    Pitson, Stuart M.
    BLOOD, 2017, 130
  • [24] JAK2 Kinase Fusion and Myeloid Involvement in Acute Lymphoblastic Leukemia
    Wang, Tong
    Ni, Jingbo
    Chen, Xue
    Cao, Panxiang
    Tan, Jinan
    Zhang, Hongwei
    Fang, Jiangcheng
    Wei, Xinying
    Chen, Jiaqi
    Ma, Xiaoli
    Zhang, Yang
    Wang, Fang
    Zhang, Yan
    Dai, Yan
    Liu, Hongxing
    BLOOD, 2023, 142
  • [25] The bcl-2 protein expression in childhood acute lymphoblastic leukemia
    Chybicka, A
    Chaber, R
    Noworolska-Sauren, D
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 269 - 270
  • [26] Bcl-2 protein and apoptosis in pediatric acute lymphoblastic leukemia
    Srinivas, G
    Kusumakumary, P
    Nair, MK
    Panicker, KR
    Pillai, MR
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1998, 1 (04) : 755 - 759
  • [27] Type II JAK2 Inhibitor NVP-CHZ868 Is Active in Vivo Against JAK2-Dependent B-Cell Acute Lymphoblastic Leukemias (B-ALLs)
    Li, Loretta S.
    Wu, Shuo-Chieh
    Kopp, Nadja
    Montero, Joan
    Ryan, Jeremy
    Chapuy, Bjoern
    Van der Zwet, Jordy C.
    Layer, Jacob
    Weigert, Oliver
    Christie, Amanda L.
    Christodoulou, Alexandra N.
    Liu, Huiyun
    Yoda, Akinori
    Hofmann, Francesco
    Baffert, Fabienne
    Vangrevelinghe, Eric
    Gaul, Christoph
    Radimerski, Thomas
    Letai, Anthony G.
    Weinstock, David M.
    BLOOD, 2014, 124 (21)
  • [28] Anti-Leukemia Activity of the Selective BCL-2 Inhibitor ABT-199 in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia Is Characterized By MCL-1/BCL-2 Expression Serving As Biomarker for Treatment Response
    Seyfried, Felix
    Demir, Salih
    Horl, Rebecca
    Kohrer, Stefan
    Scheffold, Annika
    Stilgenbauer, Stephan
    Debatin, Klaus-Michael
    Meyer, Luder Hinrich
    BLOOD, 2016, 128 (22)
  • [29] Bcl-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic Leukemia
    Diaz-Flores, Ernesto
    Comeaux, Evan Q.
    Kim, Kailyn L.
    Melnik, Ella
    Beckman, Kyle
    Davis, Kara L.
    Wu, Kevin
    Akutagawa, Jon
    Bridges, Olga
    Marino, Roberta
    Wohlfeil, Margo
    Braun, Benjamin S.
    Mullighan, Charles G.
    Loh, Mignon L.
    CANCER RESEARCH, 2019, 79 (09) : 2339 - 2351
  • [30] BCL-2 inhibition in Acute Myeloid Leukemia (AML)
    Konopleva, Marina
    Daver, Naval
    DiNardo, Courtney
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S9 - S10
12345